Group One Trading
PRCT icon

Group One Trading’s Procept Biorobotics PRCT Stock Holding History

Group One Trading’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,287
Closed -$121K – 8503
2025
Q4 		$135K Buy
+4,287
New +$142K ﹤0.01% 4729
2025
Q2 		– Sell
-420
Closed -$23.7K – 8507
2025
Q1 		$24.5K Sell
420
-1,417
-77% -$96.8K ﹤0.01% 5681
2024
Q4 		$148K Sell
1,837
-3,036
-62% -$259K ﹤0.01% 4190
2024
Q3 		$390K Buy
+4,873
New +$346K ﹤0.01% 3049
2024
Q1 		– Sell
-499
Closed -$23.8K – 7778
2023
Q4 		$20.9K Buy
+499
New +$17K ﹤0.01% 5721

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Group One Trading's PRCT Position: Q1 2026 in Review

Group One Trading sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 4,287 shares — an estimated $121K sold.

Group One Trading first reported a position in PRCT in Q4 2023 and held it in 5 quarters. The position peaked at $390K in Q3 2024. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Group One Trading reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 4,287 Procept Biorobotics shares in Q1 2026, an estimated $121K.
  • Group One Trading first reported a position in Procept Biorobotics in Q4 2023 and held it in 5 quarters.
  • Group One Trading's Procept Biorobotics position peaked at $390K in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.